Sevorane and cyanosis Patient Reports February 12, 2012

Sevorane Side Effects Report #5475260-9
Sevorane side effect was reported by a Health Professional from FRANCE on Sept 27, 2007. Male patient, 69 years of age, was diagnosed with anaesthesia and was treated with Sevorane. After drug was administered, patient experienced the following side effects: anaphylactoid shock, cyanosis, oxygen saturation decreased, urticaria. Sevorane dosage: unknown. During the same period patient was treated with REMIFENTANIL, PROPOFOL, AMOXI, FENOFIBRATE, ALLOPURINOL, TENORETIC, HYDROXYZINE. Patient was hospitalized. Patient recovered.

Sevorane Side Effects Report #5484236-7
Sevorane side effect was reported by a Health Professional from FRANCE on Oct 03, 2007. Male patient, 69 years of age, was diagnosed with anaesthesia and was treated with Sevorane. After drug was administered, patient experienced the following side effects: anaphylactoid shock, cyanosis, oxygen saturation decreased, urticaria. Sevorane dosage: unknown. During the same period patient was treated with REMIFENTANIL, PROPOFOL, AMOXI, FENOFIBRATE, ALLOPURINOL, TENORETIC, HYDROXYZINE. Patient was hospitalized. Patient recovered.

Sevorane Side Effects Report #5121129-9
Sevorane side effect was reported by a Physician from ARGENTINA on June 14, 2006. Male patient, 26 years of age, weighting 176.4 lb, was diagnosed with anaesthesia and was treated with Sevorane. After drug was administered, patient experienced the following side effects: cough, cyanosis, haemoptysis. Sevorane dosage: unknown. During the same period patient was treated with FORANE LIQUID INHALATION. Patient was hospitalized. Patient recovered.

Sevorane Side Effects Report #5033910-5
Sevorane side effect was reported by a Physician from ARGENTINA on June 14, 2006. Male patient, 26 years of age, was diagnosed with anaesthesia and was treated with Sevorane. After drug was administered, patient experienced the following side effects: cough, cyanosis, haemoptysis. Sevorane dosage: unknown. During the same period patient was treated with FORANE LIQUID INHALATION. Patient was hospitalized. Patient recovered.